Ainos Equity Warrants Exp 29 July 2027 AIMDW:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/30/22 EDT
0.75UNCH (UNCH)
Volume
41
52 week range
0.25 - 0.81
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.75
  • 52 Week High0.81
  • 52 Week High Date08/23/22
  • 52 Week Low0.25
  • 52 Week Low Date08/15/22

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.75
  • 52 Week High0.81
  • 52 Week High Date08/23/22
  • 52 Week Low0.25
  • 52 Week Low Date08/15/22
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ainos Equity Warrants Exp 29 July 2027

 

Profile

MORE
Ainos, Inc. is engaged in developing biologics for the treatment of human and animal diseases. The Company is researching for the treatment of human disease indications, including Sjogren’s syndrome, thrombocytopenia, and other indications using interferon-alpha. The Company is also developing and manufacturing point-of-care testing rapid test kit products that include diagnostics for COVID-19, pneumonia, vaginal infection and helicobacter pylori bacterial infection. Its...
Chun-Hsien Tsai
Chairman of the Board, President, Chief Executive Officer
Hui-Lan Wu
Chief Financial Officer
Lawrence Lin
Executive Vice President - Operations
Address
8880 Rio San Diego Drive, Ste. 800
San Diego, CA
92108
United States